Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Using Illusions to Boost Social Cognition (SOLLUSIONS)

19 de maio de 2026 atualizado por: Hôpital le Vinatier

Socio-cognitive Benefits of Exposure to Visual Illusions in Patients With Psychotic Disorders

This study aims to explore whether the observation of complex visual objects can help improve social cognition in people living with psychotic disorders. Social cognition refers to the ability to understand what others think, feel, or intend, and plays a key role in social relationships and daily interactions.

Main questions this study aims to answer:

  • Does dyadic exposure to complex visual objects improve mental state attribution, as measured by the Faux Pas Test?
  • Does the intervention enhance related domains of social cognition, including implicit intention inference (Hinting Task), interpretation of complex interactions (Movie for the Assessment of Social Cognition, MASC), and reduction of hostile attribution biases (Ambiguous Intentions Hostility Questionnaire, AIHQ)?
  • Are improvements maintained after one month, and do patients who receive the intervention later (waitlist group) show the same benefits once exposed?

Visão geral do estudo

Status

Ainda não está recrutando

Condições

Intervenção / Tratamento

Descrição detalhada

This study is a randomized, controlled, monocentric trial evaluating a novel sensory-motor rehabilitation approach for social cognition. The study is based on the hypothesis that perception is interpretative and viewpoint-dependent, and that realizing this through concrete experience could generalize to higher-level cognitive processes required for social understanding.

Participants will attend three visits and complete questionnaires and tasks that assess social understanding before and after the activity, and again one month later.

Two groups will take part: one completing the workshop shortly after inclusion, and one completing it after a delay, allowing comparison over time. Participants will be randomized in one condition.

This research does not involve medication. It consists of simple tasks such as observing and describing visual stimuli, followed by a facilitated discussion.

Neuropsychological tests and questionnaires will be used to measure changes over time.

Expected impact: By inducing concrete perspective-shifts, the intervention aims to improve mentalizing, reduce egocentric biases, and strengthen interpretation of social cues. This bottom-up sensory-motor approach may overcome limitations of classical cognitive remediation programs by promoting deep experiential learning rather than top-down instruction.

If effective, the method may support long-term social reintegration, psychosocial functioning, and inspire wider clinical applications due to its low cost, ease of deployment, and strong ecological engagement.

Tipo de estudo

Intervencional

Inscrição (Estimado)

60

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

Locais de estudo

  • França
      • Bron, França, 69678
        • CH le Vinatier
        • Investigador principal:
          • Frédéric HAESEBAERT, MD, PhD

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion Criteria:

  • Aged 18 to 40 years
  • Fluent French speaker
  • Has provided written informed consent
  • For individuals under guardianship (curatorship): inclusion is permitted if the curator is available to assist or advise when needed.
  • Established diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, or brief psychotic disorder according to theDiagnostic and statistical manual of mental disorders (DSM-5-TR) criteria
  • Presence of social cognition impairment, defined by:subjective complaint reported by the participant or identified by care teams regarding difficulties in social interaction and clinical confirmation of observable difficulties (e.g., social withdrawal, misinterpretation of others' intentions, inappropriate social behaviour)
  • Membership or entitlement to a social security plan

Exclusion Criteria:

  • Clinical state incompatible with participation in group-based activities (e.g., severe psychomotor agitation, severe behavioural disturbance)
  • Concurrent participation in another social cognition remediation program
  • Diagnosis of intellectual disability
  • Insufficient comprehension of French for verbal interaction and test completion
  • Significant change in psychotropic medication within the past month
  • Uncorrectable visual impairment preventing participation
  • Pregnant women
  • Individuals under full guardianship (tutorship)

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Immediate intervention
Participants receive the visual-perception session shortly after baseline assessment. They complete neurocognitive and social cognition tests before exposure, immediately after, and again at one-month follow-up.
Comportamental: Visual-illusion social cognition session (immediate)

A guided session of approximately 45 minutes. The core rehabilitation tool consists of multiple-perspective illusion boxes. Each participant stands on one side of the box and perceives a different shape than their partner. The session unfolds in 3 structured phases:

  1. For each illusion : Participants observe objects silently and draw what they see.
  2. Perspective confrontation + Card selection: Drawings and interpretation cards are exchanged and discussed.
  3. Perspective switching : Participants swap positions to reveal the alternative visual interpretation.

The session is followed by a short structured discussion with a psychologist focused on perspective-taking and interpretation of social cues.
Comparador Ativo: Delayed Intervention (Wait-list Control)
Participants complete the same assessments as Arm 1 but receive the intervention only after a waiting period. This arm allows comparison between natural progression and workshop effects prior to exposure.
Comportamental: Visual-illusion social cognition session (delayed)
A guided session of approximately 45 minutes. The core rehabilitation tool consists of multiple-perspective illusion boxes. Each participant stands on one side of the box and perceives a different shape than their partner. The session unfolds in 3 structured phases: 1. For each illusion : Participants observe objects silently and draw what they see. 2. Perspective confrontation + Card selection: Drawings and interpretation cards are exchanged and discussed. 3. Perspective switching : Participants swap positions to reveal the alternative visual interpretation. The session is followed by a short structured discussion with a psychologist focused on perspective-taking and interpretation of social cues. Delivered after a delay following baseline assessment.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
"Faux Pas" test total score
Prazo: Change from pre to post intervention (up to 3 hours)
  1. Total of correctly recognised "Faux Pas" Score range : 0 - 30 Minimum (0) : no correct detection of faux pas Maximum (30) : all faux pas correctly detected
  2. Total of identified absence of "Faux Pas" Score range : 0 - 10 Minimum (0) : incorrectly identifies absence of faux pas Maximum (10) : correctly identifies absence of faux pas
  3. Total score of control question comprehension Score range : 0 - 20 Minimum (0) : poor comprehension Maximum (20) : Full comprehension
Change from pre to post intervention (up to 3 hours)

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Hinting Task
Prazo: Change from pre to post intervention (up to 3 hours)
  1. Number of correctly inferred items with hint 1 Score range : 0 - 20 Minimum (0) : No correct inference of intentions Maximum (20) : All intentions correctly inferred
  2. Number of correctly inferred items with hint 2 Score range : 0 - 20 Minimum (0) : No correct inference of intentions Maximum (20) : All intentions correctly inferred
Change from pre to post intervention (up to 3 hours)
MASC performance
Prazo: Change from pre intervention to follow-up session (up to a month and a half)
Number of correct responses Score range 0 - 45 Minimum (0) : No correct mental state inference Maximum (45) : All mental states correctly inferred
Change from pre intervention to follow-up session (up to a month and a half)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Hôpital le Vinatier

Colaboradores

INSERM 1028

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de julho de 2026

Conclusão Primária (Estimado)

1 de janeiro de 2029

Conclusão do estudo (Estimado)

1 de fevereiro de 2029

Datas de inscrição no estudo

Enviado pela primeira vez

12 de maio de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

19 de maio de 2026

Primeira postagem (Real)

22 de maio de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

22 de maio de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

19 de maio de 2026

Última verificação

1 de maio de 2026

Mais Informações

Termos relacionados a este estudo

Palavras-chave

Termos MeSH relevantes adicionais

Outros números de identificação do estudo

  • 2025-A02057-42

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Descrição do plano IPD

Anonymized IPD that underlie results in a publication may be shared upon reasonable scientific request following publication of study results.

Prazo de Compartilhamento de IPD

IPD available after publication of primary results

Critérios de acesso de compartilhamento IPD

Requests must be made by qualified researchers for scientific purposes. Data will be shared under controlled access agreement ensuring privacy and ethical standards.

Tipo de informação de suporte de compartilhamento de IPD

  • PROTOCOLO DE ESTUDO
  • SEIVA

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever